MSLE Satellos Bioscience Inc.
Price Chart
Executive Summary
Satellos Bioscience Inc. filed its management information circular and proxy materials for the June 17, 2026 annual general meeting. The filing covers routine matters: election of nine director nominees, appointment of PricewaterhouseCoopers as auditors, and receipt of FY2025 audited financial statements. No material financial data, business updates, or strategic changes are disclosed — this is a standard annual meeting solicitation with no actionable trading implications.
Actionable Insight
No trading action warranted. This is a standard annual meeting proxy filing with no earnings, guidance, or material corporate developments. Monitor for Phase 2 clinical data readouts for SAT-3247 in Duchenne muscular dystrophy as the next potential catalyst.
Key Facts
- Annual general meeting scheduled for June 17, 2026, in virtual-only format
- Shareholders to vote on election of 9 director nominees and appointment of PwC as auditors
- As of May 14, 2026, 20,831,190 common shares outstanding (post-12:1 consolidation on Jan 27, 2026)
- No 10%+ beneficial holders identified
- Equity Incentive Plan has 358,116 shares available for future grants (~1.7% of outstanding)
- FY2025 audited financial statements to be presented but no shareholder vote required
Financial Impact
No financial impact — routine proxy solicitation with no material business or financial disclosures
Risk Factors
- No material risks disclosed beyond standard forward-looking statement cautionary language
Market Snapshot
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003561 |
| Exhibit: exh_993.htm | 0001171843-26-003561 |
| Exhibit: exh_992.htm | 0001171843-26-003561 |
| Exhibit: exh_994.htm | 0001171843-26-003561 |
| Document: f6k_051926.htm | 0001171843-26-003561 |
| Document: 0001171843-26-003561-index-headers.html | 0001171843-26-003561 |
| Document: 0001171843-26-003561-index.html | 0001171843-26-003561 |
| Document: 0001171843-26-003561.txt | 0001171843-26-003561 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
25d ago
|
6-K
| $7.36 $7.03 | ▼ −4.42% | ▼ −6.22% | $5.75 (−21.82%) |
|
May 15, 2026
4w ago
|
6-K
| $7.01 $6.75 | ▼ −3.71% | ▼ −4.67% | $5.75 (−17.97%) |
|
May 15, 2026
4w ago
|
Press Release
| $7.01 $6.75 | ▼ −3.71% | ▼ −4.67% | $5.75 (−17.97%) |
|
Apr 9, 2026
9w ago
|
6-K
| $6.20 $8.59 | ▲ +38.55% | ▲ +35.36% | $5.75 (−7.26%) |
|
Mar 27, 2026
11w ago
|
6-K
| $6.19 $5.65 | ▼ −8.72% | ▼ −12.59% | $5.75 (−7.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access